These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17074798)

  • 1. Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.
    Liu P; Foster G; Labadie R; Somoza E; Sharma A
    Antimicrob Agents Chemother; 2007 Jan; 51(1):110-8. PubMed ID: 17074798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.
    Liu P; Foster G; Gandelman K; LaBadie RR; Allison MJ; Gutierrez MJ; Sharma A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3617-26. PubMed ID: 17646413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
    Liu P; Foster G; LaBadie RR; Gutierrez MJ; Sharma A
    J Clin Pharmacol; 2008 Jan; 48(1):73-84. PubMed ID: 18025525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
    J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fluconazole on the clinical pharmacokinetics of methadone.
    Cobb MN; Desai J; Brown LS; Zannikos PN; Rainey PM
    Clin Pharmacol Ther; 1998 Jun; 63(6):655-62. PubMed ID: 9663180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.
    Purkins L; Wood N; Ghahramani P; Greenhalgh K; Allen MJ; Kleinermans D
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2546-53. PubMed ID: 12121931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
    Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Vyyryläinen H; Laine K
    Antimicrob Agents Chemother; 2006 Jun; 50(6):1967-72. PubMed ID: 16723553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    Purkins L; Wood N; Ghahramani P; Love ER; Eve MD; Fielding A
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
    Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Dowell JA; Schranz J; Baruch A; Foster G
    J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
    Romero AJ; Le Pogamp P; Nilsson LG; Wood N
    Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
    Purkins L; Wood N; Kleinermans D; Love ER
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):62-8. PubMed ID: 14616416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers.
    Schöller-Gyüre M; van den Brink W; Kakuda TN; Woodfall B; De Smedt G; Vanaken H; Stevens T; Peeters M; Vandermeulen K; Hoetelmans RM
    J Clin Pharmacol; 2008 Mar; 48(3):322-9. PubMed ID: 18195053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
    Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
    Purkins L; Wood N; Ghahramani P; Kleinermans D; Layton G; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):30-6. PubMed ID: 14616411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
    Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
    Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
    Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN
    Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics and metabolism of voriconazole in patients.
    Geist MJ; Egerer G; Burhenne J; Riedel KD; Weiss J; Mikus G
    J Antimicrob Chemother; 2013 Nov; 68(11):2592-9. PubMed ID: 23766489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
    Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
    Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.